Katy Sivyer
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Katy Sivyer has a total of 143 co-authors. Here are the top co-authors by number of shared publications:
- Lucy Yardley
University of Oxford
12 shared publications - Kate Greenwell
Primary Care Research Centre, School of Primary Care, Population Sciences and Medical Education, Faculty of Medicine, University of Southampton, Southampton, UK; Clinical and Experimental Sciences, Faculty of Medicine, University of Southampton, Southampton, UK
9 shared publications - Miriam Santer
Primary Care Research Centre University of Southampton Southampton UK
8 shared publications - Ingrid Muller
Primary Care Research Centre, University of Southampton , Southampton
7 shared publications - Kim Suzanne Thomas
School of Medicine, University of Nottingham , Nottingham
7 shared publications - Laura Howells
Centre of Evidence Based Dermatology, School of Medicine, University of Nottingham, Nottingham, UK
6 shared publications
Latest Publications
- Open Access
- 14 August 2026
- Published by JMIR Publications Inc. in JMIR Research Protocols
- Vol. 15, e91900
Feasibility of an Online Shared Reading Intervention in Survivors of Gynecological Cancer: Protocol for a Multiple-Baseline Single-Case Study
Background: Gynecological cancers pose significant physical, psychological, and social challenges for those affected. Although psychosocial interventions are components of holistic cancer care, access can be limited by specialized practitioner expertise, wait times, gender-biased care, and accessibility constraints. These barriers highlight a recognized need for alternative, timely, and nonclinical approaches that can complement existing services and relieve system pressures. Objective: The primary study aim is to evaluate the feasibility and acceptability of an online shared reading program as a novel, adjunctive psychosocial intervention for people affected by gynecological cancers. The secondary aim is to explore the intervention’s preliminary individual-level outcomes on psychological distress, well-being, and quality of life. Methods: This mixed methods feasibility study uses a multiple-baseline single-case design informed by a realist evaluation theoretical framework. Up to 10 participants aged 18 years or older with a primary diagnosis of gynecological cancer will be recruited internationally. The intervention consists of 6 weekly 1-hour literature reading group sessions delivered via Microsoft Teams. Three baseline assessments at −2 weeks, −1 week, and week 0 will establish outcome stability prior to the intervention, followed by midintervention (week 3) and postintervention (week 6) assessments. Outcome measures include the Short Warwick-Edinburgh Mental Wellbeing Scale, the Kessler Psychological Distress Scale, the WHOQOL-BREF social domain subscale, and 2 global quality of life items from the EORTC QLQ-C30. Individual-level change within these measures will be examined using the reliable change index at a threshold of 1.96 or higher, presented as modified Brinley plots. Feasibility will be assessed and summarized descriptively using recruitment and retention rates, session attendance and completion rates, and reasons for dropout. Acceptability will be examined through semistructured interviews of up to 30 minutes conducted by an independent researcher after the intervention. Interview data will be analyzed using reflexive thematic analysis to explore participants’ intervention experience and perceived mechanisms of change. Results: This feasibility study was funded in October 2022 as part of a PhD scholarship. Recruitment began in November 2025 and continued until March 2026. At the time of manuscript submission in January 2026, a total of 6 people had registered their interest, of whom 2 met the eligibility criteria. The data analysis plan was formulated but not implemented, with the intervention set to begin in May 2026. Findings are expected to be submitted for publication in November 2026. Conclusions: Potential implications include that the digital, low-intensity, group-based online shared reading format may offer a novel psychosocial support alternative to survivors of gynecological cancer who may be otherwise excluded due to residing in geographically remote areas, financial constraints, or reluctance to engage with formal psychological therapy. If feasible and acceptable, the intervention may contribute to equitable cancer care provision and inform the design of future implementation studies in digital oncology services.
- 14 August 2026
- Published by JMIR Publications Inc. in JMIR Research Protocols
- Vol. 15, e91900
Open AccessFeasibility of an Online Shared Reading Intervention in Survivors of Gynecological Cancer: Protocol for a Multiple-Baseline Single-Case Study
Background: Gynecological cancers pose significant physical, psychological, and social challenges for those affected. Although psychosocial interventions are components of holistic cancer care, access can be limited by specialized practitioner expertise, wait times, gender-biased care, and accessibility constraints. These barriers highlight a recognized need for alternative, timely, and nonclinical approaches that can complement existing services and relieve system pressures. Objective: The primary study aim is to evaluate the feasibility and acceptability of an online shared reading program as a novel, adjunctive psychosocial intervention for people affected by gynecological cancers. The secondary aim is to explore the intervention’s preliminary individual-level outcomes on psychological distress, well-being, and quality of life. Methods: This mixed methods feasibility study uses a multiple-baseline single-case design informed by a realist evaluation theoretical framework. Up to 10 participants aged 18 years or older with a primary diagnosis of gynecological cancer will be recruited internationally. The intervention consists of 6 weekly 1-hour literature reading group sessions delivered via Microsoft Teams. Three baseline assessments at −2 weeks, −1 week, and week 0 will establish outcome stability prior to the intervention, followed by midintervention (week 3) and postintervention (week 6) assessments. Outcome measures include the Short Warwick-Edinburgh Mental Wellbeing Scale, the Kessler Psychological Distress Scale, the WHOQOL-BREF social domain subscale, and 2 global quality of life items from the EORTC QLQ-C30. Individual-level change within these measures will be examined using the reliable change index at a threshold of 1.96 or higher, presented as modified Brinley plots. Feasibility will be assessed and summarized descriptively using recruitment and retention rates, session attendance and completion rates, and reasons for dropout. Acceptability will be examined through semistructured interviews of up to 30 minutes conducted by an independent researcher after the intervention. Interview data will be analyzed using reflexive thematic analysis to explore participants’ intervention experience and perceived mechanisms of change. Results: This feasibility study was funded in October 2022 as part of a PhD scholarship. Recruitment began in November 2025 and continued until March 2026. At the time of manuscript submission in January 2026, a total of 6 people had registered their interest, of whom 2 met the eligibility criteria. The data analysis plan was formulated but not implemented, with the intervention set to begin in May 2026. Findings are expected to be submitted for publication in November 2026. Conclusions: Potential implications include that the digital, low-intensity, group-based online shared reading format may offer a novel psychosocial support alternative to survivors of gynecological cancer who may be otherwise excluded due to residing in geographically remote areas, financial constraints, or reluctance to engage with formal psychological therapy. If feasible and acceptable, the intervention may contribute to equitable cancer care provision and inform the design of future implementation studies in digital oncology services.
- Open Access
- 1 July 2026
- Published by National Institute for Health and Care Research in Programme Grants for Applied Research
- p. 1-82
Optimising antibiotic ‘review and revise’ in acute/general medical inpatients: the Antibiotic Review Kit in Hospitals (ARK-Hospital) research programme including a stepped-wedge cluster-randomised trial
Background: Patients who present acutely to hospital are often suspected to have bacterial infections and are prescribed antibiotics rapidly. Emerging diagnostic information then shows many of these prescriptions were, or no longer are, necessary, requiring prescribers to stop antibiotics: but there is little evidence for how to support this. United Kingdom ‘Start Smart then Focus’ guidance promotes early effective antibiotics followed by active ‘review and revision’ 24–72 hours later. However, in 2017 < 10% of antibiotic prescriptions were discontinued at review, despite studies suggesting that 20–30% could be stopped safely but are not, largely because of behavioural and organisational factors. Objectives: To develop and comprehensively evaluate a complex digital, organisational and behavioural change intervention (i.e. the Antibiotic Review Kit) designed to reduce antibiotic use among adult acute/general medical inpatients by increasing appropriate decisions to stop antibiotics at clinical review. Design and methods: To provide underpinning data to design the intervention, we conducted: (1) an overview of the systematic review evidence for the effectiveness and safety of shorter versus longer antibiotic courses in hospitalised patients; (2) hospital-level and individual-level observational analyses of electronic health records to investigate associations between antibiotic usage and outcomes in inpatients; and (3) qualitative studies with healthcare professionals and patients/carers to deepen understanding of perceptions and experiences of inpatient antibiotic prescribing and to identify amenable barriers to change. We used findings from these studies to develop a multi-component healthcare professional and inpatient/carer intervention to support antibiotic ‘review and revise’, using a theory-, evidence- and person-based approach with iterative stakeholder consultation, and targeting practicality, generalisability and sustainability. We then tested its feasibility in one hospital, evaluated using mixed methods, before evaluating its effectiveness and safety in acute/general medical admissions in a non-randomised internal pilot in three hospitals and then a large randomised stepped-wedge cluster trial in 36 hospitals (randomisation unit) across the United Kingdom. The intervention was implemented in two hospitals per month over approximately 18 months. A further minimum 14-month follow-up in all hospitals assessed sustainability of any intervention effect. Analyses used meta-analytic techniques to combine hospital-specific immediate intervention effects (step-change) and underlying trends pre and post implementation, derived using negative binomial regression models for antibiotic outcomes and logistic regression models for binary outcomes. Process evaluation assessed which intervention components were used/useful. Setting and participants: Acute/general medical specialties in acute hospital groups; participants were prescribers and non-prescribers involved in decision-making around stopping antibiotics and the inpatients themselves. Interventions: The Antibiotic Review Kit comprised short internet-based training, standardised systems to review patients (the Antibiotic Review Kit decision aid), regular support from pharmacists/infection specialists through audit and feedback and an information leaflet for patients. Main outcome measures: Coprimary outcomes were 30-day mortality post-admission (non-inferiority) and defined-daily-doses of antibiotics per acute/general medical admission (superiority). Data sources: All outcomes were collected from routine electronic National Health Service databases. Results: A key barrier to stopping antibiotics was lack of information about the original prescriber’s rationale for, and degree of certainty about their initial antibiotic prescribing decision. An integral component of the Antibiotic Review Kit was developing and optimising a decision aid to increase transparency around initial prescribing decisions. In the 3 pilot and 36 main trial sites (total = 39) who implemented the intervention between 25 September 2017 and 1 July 2019, adjusted estimates showed an immediate change of –1.0% [(95% confidence interval −4.0 to +2.1); p = 0.54] in total antibiotic defined daily doses per acute/general medical admission following the intervention and then sustained reductions of −4.8% per year (−9.1 to −0.2) ( p = 0.042) greater post versus pre implementation. Among 7,160,421 acute/general medical admissions, the Antibiotic Review Kit intervention was associated with weak evidence of an immediate change of −2.7% [(−5.7 to +0.3); p = 0.079] in adjusted 30-day mortality and a year-on-year post versus pre implementation change of +3.0% per year [(−0.1 to +6.2); p = 0.060]; the latter was not found after excluding admissions after the COVID-19 pandemic started in March 2020 [year-on-year change −0.9% (−4.0 to + 2.4) ( p = 0.60)]. Limitations: COVID-19 had an important impact during the trial, and necessitated changes to the statistical analysis plan that could not have been foreseen. It also affected our ability to assess cost-effectiveness, since estimates were strongly affected by non-significant mortality excesses which were plausibly due to COVID-19. Conclusions: The Antibiotic Review Kit intervention resulted in sustained reductions in antibiotic use among adult acute/general medical inpatients. The weak, inconsistent intervention effects suggesting a possible initial decrease in mortality associated with the intervention, followed by a longer-term increase, are likely due to the COVID-19 pandemic. Hospitals should consider using the Antibiotic Review Kit to reduce antibiotic overuse. Future work: Most sites were using paper-based prescribing systems during the trial; implementing the Antibiotic Review Kit in electronic-based prescribing, now used by almost all National Health Service Trusts, can be more complex. Further research is needed to support recommendations for the Antibiotic Review Kit, and antimicrobial stewardship functionality more widely, in electronic prescribing systems. Study registration: The overview of systematic reviews was registered with PROSPERO (CRD42016046907). The feasibility, pilot and main cluster-randomised trial was registered with ISRCTN (ISRCTN12674243). Funding: This award was funded by the National Institute for Health and Care Research (NIHR) Programme Grants for Applied Research Programme (NIHR award ref: RP-PG-0514-20015) and is published in full in Programme Grants for Applied Research ; Vol. 14, No. 10. See the NIHR Funding and Awards website for further award information.
- 1 July 2026
- Published by National Institute for Health and Care Research in Programme Grants for Applied Research
- p. 1-82
Open AccessOptimising antibiotic ‘review and revise’ in acute/general medical inpatients: the Antibiotic Review Kit in Hospitals (ARK-Hospital) research programme including a stepped-wedge cluster-randomised trial
Background: Patients who present acutely to hospital are often suspected to have bacterial infections and are prescribed antibiotics rapidly. Emerging diagnostic information then shows many of these prescriptions were, or no longer are, necessary, requiring prescribers to stop antibiotics: but there is little evidence for how to support this. United Kingdom ‘Start Smart then Focus’ guidance promotes early effective antibiotics followed by active ‘review and revision’ 24–72 hours later. However, in 2017 < 10% of antibiotic prescriptions were discontinued at review, despite studies suggesting that 20–30% could be stopped safely but are not, largely because of behavioural and organisational factors. Objectives: To develop and comprehensively evaluate a complex digital, organisational and behavioural change intervention (i.e. the Antibiotic Review Kit) designed to reduce antibiotic use among adult acute/general medical inpatients by increasing appropriate decisions to stop antibiotics at clinical review. Design and methods: To provide underpinning data to design the intervention, we conducted: (1) an overview of the systematic review evidence for the effectiveness and safety of shorter versus longer antibiotic courses in hospitalised patients; (2) hospital-level and individual-level observational analyses of electronic health records to investigate associations between antibiotic usage and outcomes in inpatients; and (3) qualitative studies with healthcare professionals and patients/carers to deepen understanding of perceptions and experiences of inpatient antibiotic prescribing and to identify amenable barriers to change. We used findings from these studies to develop a multi-component healthcare professional and inpatient/carer intervention to support antibiotic ‘review and revise’, using a theory-, evidence- and person-based approach with iterative stakeholder consultation, and targeting practicality, generalisability and sustainability. We then tested its feasibility in one hospital, evaluated using mixed methods, before evaluating its effectiveness and safety in acute/general medical admissions in a non-randomised internal pilot in three hospitals and then a large randomised stepped-wedge cluster trial in 36 hospitals (randomisation unit) across the United Kingdom. The intervention was implemented in two hospitals per month over approximately 18 months. A further minimum 14-month follow-up in all hospitals assessed sustainability of any intervention effect. Analyses used meta-analytic techniques to combine hospital-specific immediate intervention effects (step-change) and underlying trends pre and post implementation, derived using negative binomial regression models for antibiotic outcomes and logistic regression models for binary outcomes. Process evaluation assessed which intervention components were used/useful. Setting and participants: Acute/general medical specialties in acute hospital groups; participants were prescribers and non-prescribers involved in decision-making around stopping antibiotics and the inpatients themselves. Interventions: The Antibiotic Review Kit comprised short internet-based training, standardised systems to review patients (the Antibiotic Review Kit decision aid), regular support from pharmacists/infection specialists through audit and feedback and an information leaflet for patients. Main outcome measures: Coprimary outcomes were 30-day mortality post-admission (non-inferiority) and defined-daily-doses of antibiotics per acute/general medical admission (superiority). Data sources: All outcomes were collected from routine electronic National Health Service databases. Results: A key barrier to stopping antibiotics was lack of information about the original prescriber’s rationale for, and degree of certainty about their initial antibiotic prescribing decision. An integral component of the Antibiotic Review Kit was developing and optimising a decision aid to increase transparency around initial prescribing decisions. In the 3 pilot and 36 main trial sites (total = 39) who implemented the intervention between 25 September 2017 and 1 July 2019, adjusted estimates showed an immediate change of –1.0% [(95% confidence interval −4.0 to +2.1); p = 0.54] in total antibiotic defined daily doses per acute/general medical admission following the intervention and then sustained reductions of −4.8% per year (−9.1 to −0.2) ( p = 0.042) greater post versus pre implementation. Among 7,160,421 acute/general medical admissions, the Antibiotic Review Kit intervention was associated with weak evidence of an immediate change of −2.7% [(−5.7 to +0.3); p = 0.079] in adjusted 30-day mortality and a year-on-year post versus pre implementation change of +3.0% per year [(−0.1 to +6.2); p = 0.060]; the latter was not found after excluding admissions after the COVID-19 pandemic started in March 2020 [year-on-year change −0.9% (−4.0 to + 2.4) ( p = 0.60)]. Limitations: COVID-19 had an important impact during the trial, and necessitated changes to the statistical analysis plan that could not have been foreseen. It also affected our ability to assess cost-effectiveness, since estimates were strongly affected by non-significant mortality excesses which were plausibly due to COVID-19. Conclusions: The Antibiotic Review Kit intervention resulted in sustained reductions in antibiotic use among adult acute/general medical inpatients. The weak, inconsistent intervention effects suggesting a possible initial decrease in mortality associated with the intervention, followed by a longer-term increase, are likely due to the COVID-19 pandemic. Hospitals should consider using the Antibiotic Review Kit to reduce antibiotic overuse. Future work: Most sites were using paper-based prescribing systems during the trial; implementing the Antibiotic Review Kit in electronic-based prescribing, now used by almost all National Health Service Trusts, can be more complex. Further research is needed to support recommendations for the Antibiotic Review Kit, and antimicrobial stewardship functionality more widely, in electronic prescribing systems. Study registration: The overview of systematic reviews was registered with PROSPERO (CRD42016046907). The feasibility, pilot and main cluster-randomised trial was registered with ISRCTN (ISRCTN12674243). Funding: This award was funded by the National Institute for Health and Care Research (NIHR) Programme Grants for Applied Research Programme (NIHR award ref: RP-PG-0514-20015) and is published in full in Programme Grants for Applied Research ; Vol. 14, No. 10. See the NIHR Funding and Awards website for further award information.
- Open Access
- 16 July 2025
- Published by Elsevier in Obesity Research & Clinical Practice
- Vol. 19 (4) , 326-333
A qualitative exploration of couples’ expectations and experiences of adjusting to changes following metabolic and bariatric surgery
- 16 July 2025
- Published by Elsevier in Obesity Research & Clinical Practice
- Vol. 19 (4) , 326-333
Open AccessA qualitative exploration of couples’ expectations and experiences of adjusting to changes following metabolic and bariatric surgery
- Open Access
- 1 March 2025
- Published by National Institute for Health and Care Research in Programme Grants for Applied Research
- p. 1-92
Supporting self-care for eczema in the community: the Eczema Care Online research programme including two RCTs
Background: Eczema is a common condition with significant impact on quality of life. The main cause of treatment failure is non-use of prescribed treatments because treatments are time-consuming to apply; they may sting when first applied to inflamed skin; there are concerns about the safety of some treatments; and because people often receive conflicting advice about how and when to use them. Objectives: Objectives of the present study are to: (1) explore the self-care support needs of children with eczema and their parents/carers, and young people with eczema, (2) review current best evidence about the safest and best ways to use topical corticosteroids for eczema, (3) develop theory-, evidence- and person-based online interventions to support eczema self-management in young people with eczema and parents/carers of children with eczema, (4) evaluate the clinical and cost-effectiveness of the interventions in two randomised controlled trials and (5) conduct a process evaluation and implementation planning. Design: Five qualitative studies, four systematic reviews (one qualitative) and two parallel randomised controlled trials with nested process evaluation and economic evaluation. Setting: Primary care. Participants: Children and young people aged 13–25 years with eczema, and parents/carers of children aged 0–12 years with eczema. Participants with very mild or inactive eczema were excluded. Interventions: We developed and evaluated two online behavioural interventions to support eczema management in: (1) young people and (2) parents/carers of children. Participants were not blinded to group allocation. Main outcome measures: Primary outcome measure in the randomised controlled trials was participant-reported eczema severity measured by the patient-oriented eczema measure over 24 weeks. Secondary outcomes included patient-oriented eczema measures over 52 weeks, quality of life and patient enablement. Results: Qualitative reviews and interviews provided in-depth understanding of the views, experiences and contexts within which young people and families manage eczema and identified barriers and facilitators to key behaviours. Systematic literature reviews on topical corticosteroid safety and effectiveness found no evidence of harm when topical corticosteroids were used intermittently to treat or prevent eczema flares. Our Cochrane review, which included 104 trials (8443 participants), found that potent and moderate topical corticosteroids are probably more effective than mild topical corticosteroids for treating moderate or severe eczema and that effectiveness is similar between once and twice daily use. Findings informed development of two online interventions, which were evaluated in two randomised controlled trials comparing intervention plus usual care to usual care only. Three hundred and forty parents/carers (169 usual care; 171 intervention) and 337 young people (169 usual care; 168 intervention) were randomised [mean baseline patient-oriented eczema measure 12.8 (standard deviation 5.3) and 15.2 (standard deviation 5.4), respectively]. An intention-to-treat analysis approach to the analysis was taken. Follow-up rates were: 92.4% (314/340) parents/carers and 90.2% (304/337) young people at 24 weeks. Compared with usual care over 24 weeks, eczema severity (patient-oriented eczema measure) improved in the intervention groups: adjusted mean difference −1.5 (95% confidence interval −2.5 to −0.6) for parents/carers, and −1.9 (95% confidence interval −3.0 to −0.8) for young people. Effects were sustained for 52 weeks in both groups. Enablement showed an important difference favouring the intervention group in both trials [adjusted mean difference at 24 weeks −0.7 (95% confidence interval −1.0 to −0.4) for parents/carers and −0.9 (95% confidence interval −1.3 to −0.6) for young people]. No harms were identified in either group. Economic analysis found both interventions were low cost and cost-effective with almost all analyses (with the exception of the complete-case cost–utility analysis for the parent/carer trial) estimating the interventions to be dominant (cost saving and effective). Process evaluation demonstrated that both groups found the interventions usable, relatable and trustworthy, and perceived that they helped to manage their eczema. The interventions have been redeveloped into an English and Welsh product ready for dissemination and an implementation strategy has been developed. Limitations: This research was conducted during the COVID-19 pandemic. While this did not have a major impact on our research plans or delivery, it may have had impacts (positive and negative) on people’s eczema, their eczema management and access to health care. Conclusions: Eczema Care Online is effective and acceptable to its target groups. Findings from this programme support the wide-scale implementation of the interventions, available at www.eczemacareonline.org.uk. Future work: Future work may explore how Eczema Care Online can be implemented in different settings and contexts and adapted for severe eczema. More research is also needed on the long-term safety of topical corticosteroids. Trial registration: This trial is registered as Current Controlled Trials ISRCTN79282252. Funding: This award was funded by the National Institute for Health and Care Research (NIHR) Programme Grants for Applied Research programme (NIHR award ref: RP-PG-0216-20007) and is published in full in Programme Grants for Applied Research; Vol. 13, No. 3. See the NIHR Funding and Awards website for further award information.
- 1 March 2025
- Published by National Institute for Health and Care Research in Programme Grants for Applied Research
- p. 1-92
Open AccessSupporting self-care for eczema in the community: the Eczema Care Online research programme including two RCTs
Background: Eczema is a common condition with significant impact on quality of life. The main cause of treatment failure is non-use of prescribed treatments because treatments are time-consuming to apply; they may sting when first applied to inflamed skin; there are concerns about the safety of some treatments; and because people often receive conflicting advice about how and when to use them. Objectives: Objectives of the present study are to: (1) explore the self-care support needs of children with eczema and their parents/carers, and young people with eczema, (2) review current best evidence about the safest and best ways to use topical corticosteroids for eczema, (3) develop theory-, evidence- and person-based online interventions to support eczema self-management in young people with eczema and parents/carers of children with eczema, (4) evaluate the clinical and cost-effectiveness of the interventions in two randomised controlled trials and (5) conduct a process evaluation and implementation planning. Design: Five qualitative studies, four systematic reviews (one qualitative) and two parallel randomised controlled trials with nested process evaluation and economic evaluation. Setting: Primary care. Participants: Children and young people aged 13–25 years with eczema, and parents/carers of children aged 0–12 years with eczema. Participants with very mild or inactive eczema were excluded. Interventions: We developed and evaluated two online behavioural interventions to support eczema management in: (1) young people and (2) parents/carers of children. Participants were not blinded to group allocation. Main outcome measures: Primary outcome measure in the randomised controlled trials was participant-reported eczema severity measured by the patient-oriented eczema measure over 24 weeks. Secondary outcomes included patient-oriented eczema measures over 52 weeks, quality of life and patient enablement. Results: Qualitative reviews and interviews provided in-depth understanding of the views, experiences and contexts within which young people and families manage eczema and identified barriers and facilitators to key behaviours. Systematic literature reviews on topical corticosteroid safety and effectiveness found no evidence of harm when topical corticosteroids were used intermittently to treat or prevent eczema flares. Our Cochrane review, which included 104 trials (8443 participants), found that potent and moderate topical corticosteroids are probably more effective than mild topical corticosteroids for treating moderate or severe eczema and that effectiveness is similar between once and twice daily use. Findings informed development of two online interventions, which were evaluated in two randomised controlled trials comparing intervention plus usual care to usual care only. Three hundred and forty parents/carers (169 usual care; 171 intervention) and 337 young people (169 usual care; 168 intervention) were randomised [mean baseline patient-oriented eczema measure 12.8 (standard deviation 5.3) and 15.2 (standard deviation 5.4), respectively]. An intention-to-treat analysis approach to the analysis was taken. Follow-up rates were: 92.4% (314/340) parents/carers and 90.2% (304/337) young people at 24 weeks. Compared with usual care over 24 weeks, eczema severity (patient-oriented eczema measure) improved in the intervention groups: adjusted mean difference −1.5 (95% confidence interval −2.5 to −0.6) for parents/carers, and −1.9 (95% confidence interval −3.0 to −0.8) for young people. Effects were sustained for 52 weeks in both groups. Enablement showed an important difference favouring the intervention group in both trials [adjusted mean difference at 24 weeks −0.7 (95% confidence interval −1.0 to −0.4) for parents/carers and −0.9 (95% confidence interval −1.3 to −0.6) for young people]. No harms were identified in either group. Economic analysis found both interventions were low cost and cost-effective with almost all analyses (with the exception of the complete-case cost–utility analysis for the parent/carer trial) estimating the interventions to be dominant (cost saving and effective). Process evaluation demonstrated that both groups found the interventions usable, relatable and trustworthy, and perceived that they helped to manage their eczema. The interventions have been redeveloped into an English and Welsh product ready for dissemination and an implementation strategy has been developed. Limitations: This research was conducted during the COVID-19 pandemic. While this did not have a major impact on our research plans or delivery, it may have had impacts (positive and negative) on people’s eczema, their eczema management and access to health care. Conclusions: Eczema Care Online is effective and acceptable to its target groups. Findings from this programme support the wide-scale implementation of the interventions, available at www.eczemacareonline.org.uk. Future work: Future work may explore how Eczema Care Online can be implemented in different settings and contexts and adapted for severe eczema. More research is also needed on the long-term safety of topical corticosteroids. Trial registration: This trial is registered as Current Controlled Trials ISRCTN79282252. Funding: This award was funded by the National Institute for Health and Care Research (NIHR) Programme Grants for Applied Research programme (NIHR award ref: RP-PG-0216-20007) and is published in full in Programme Grants for Applied Research; Vol. 13, No. 3. See the NIHR Funding and Awards website for further award information.
- Open Access
- 31 January 2025
- Published by Springer Nature in BMC Health Services Research
- Vol. 25 (1) , 1-10
Evidence to practice – lessons learnt in developing an implementation strategy for an online digital health intervention (Eczema Care Online)
Background: Eczema Care Online (www.EczemaCareOnline.org.uk/) is an online self-management toolkit which includes tailored content for young people (13–25 years) and for parents of children that have eczema (0–12 years). Testing in two randomised controlled trials has shown that it is easy to use, cost effective and offers a sustained improvement in eczema symptoms. Implementing Eczema Care Online outside of a funded research study and ensuring that it reaches those that will most benefit from is now a key challenge. This paper describes the lessons learnt from developing and delivering an implementation strategy. Methods: Data from systematic reviews, stakeholder consultation meetings, interviews with trial participants, intervention usage data during the trial, and existing eczema information websites informed our implementation plan. Using Normalisation Process Theory, an implementation plan combined these findings with practical, context-specific actions to encourage wider adoption of the intervention. Results: Data was successfully mapped to the four constructs of Normalisation Process Theory, and factors and processes that encourage implementation identified. These include: promoting how Eczema Care Online is different to other sources of information; aligning to and embedding in existing eczema resources (from charities and healthcare providers); simplifying aspects to aid ease of use; and, highlighting evidence that shows that Eczema Care Online works. Key lessons in developing an implementation strategy include 1) start implementation work early 2) maintain flexibility to explore multiple routes to implementation 3) use secondary data sources 4) balance theory with practicalities 5) consider longer-term maintenance beyond the life of the research project. Conclusion: Implementation planning is a key stage of the research process that is often not adequately resourced. Implementation planning ensures effective interventions developed and evaluated in research studies are utilised in everyday practice.
- 31 January 2025
- Published by Springer Nature in BMC Health Services Research
- Vol. 25 (1) , 1-10
Open AccessEvidence to practice – lessons learnt in developing an implementation strategy for an online digital health intervention (Eczema Care Online)
Background: Eczema Care Online (www.EczemaCareOnline.org.uk/) is an online self-management toolkit which includes tailored content for young people (13–25 years) and for parents of children that have eczema (0–12 years). Testing in two randomised controlled trials has shown that it is easy to use, cost effective and offers a sustained improvement in eczema symptoms. Implementing Eczema Care Online outside of a funded research study and ensuring that it reaches those that will most benefit from is now a key challenge. This paper describes the lessons learnt from developing and delivering an implementation strategy. Methods: Data from systematic reviews, stakeholder consultation meetings, interviews with trial participants, intervention usage data during the trial, and existing eczema information websites informed our implementation plan. Using Normalisation Process Theory, an implementation plan combined these findings with practical, context-specific actions to encourage wider adoption of the intervention. Results: Data was successfully mapped to the four constructs of Normalisation Process Theory, and factors and processes that encourage implementation identified. These include: promoting how Eczema Care Online is different to other sources of information; aligning to and embedding in existing eczema resources (from charities and healthcare providers); simplifying aspects to aid ease of use; and, highlighting evidence that shows that Eczema Care Online works. Key lessons in developing an implementation strategy include 1) start implementation work early 2) maintain flexibility to explore multiple routes to implementation 3) use secondary data sources 4) balance theory with practicalities 5) consider longer-term maintenance beyond the life of the research project. Conclusion: Implementation planning is a key stage of the research process that is often not adequately resourced. Implementation planning ensures effective interventions developed and evaluated in research studies are utilised in everyday practice.
- Open Access
- 5 February 2024
- Published by Royal College of General Practitioners in British Journal of General Practice
- Vol. 74 (743) , E393-E400
Online behavioural interventions for children and young people with eczema: a quantitative evaluation
Background: Two online behavioural interventions (one website for parents/carers of children with eczema; and one for young people with eczema) have been shown in randomised controlled trials to facilitate a sustained improvement in eczema severity.Aim: To describe intervention use and examine potential mediators of intervention outcomes and contextual factors that may influence intervention delivery and outcomes.Design and setting: Quantitative process evaluation in UK primary care.Method: Parents/carers and young people were recruited through primary care. Intervention use was recorded and summarised descriptively. Logistic regression explored sociodemographic and other factors associated with intervention engagement. Mediation analysis investigated whether patient enablement (ability to understand and cope with health issues), treatment use, and barriers to adherence were mediators of intervention effect. Subgroup analysis compared intervention effects among pre-specified participant subsets.Results: A total of 340 parents/carers and 337 young people were recruited. Most parents/carers (87%,n= 148/171) and young people (91%,n= 153/168) in the intervention group viewed the core introduction by 24 weeks. At 24 weeks, users had spent approximately 20 minutes on average on the interventions. Among parents/carers, greater intervention engagement was associated with higher education levels, uncertainty about carrying out treatments, and doubts about treatment efficacy at baseline. Among young people, higher intervention use was associated with higher baseline eczema severity. Patient enablement (the ability to understand and cope with health issues) accounted for approximately 30% of the intervention effect among parents/carers and 50% among young people.Conclusion: This study demonstrated that positive intervention outcomes depended on a modest time commitment from users. This provides further support that the wider implementation of Eczema Care Online is justified.
- 5 February 2024
- Published by Royal College of General Practitioners in British Journal of General Practice
- Vol. 74 (743) , E393-E400
Open AccessOnline behavioural interventions for children and young people with eczema: a quantitative evaluation
Background: Two online behavioural interventions (one website for parents/carers of children with eczema; and one for young people with eczema) have been shown in randomised controlled trials to facilitate a sustained improvement in eczema severity.Aim: To describe intervention use and examine potential mediators of intervention outcomes and contextual factors that may influence intervention delivery and outcomes.Design and setting: Quantitative process evaluation in UK primary care.Method: Parents/carers and young people were recruited through primary care. Intervention use was recorded and summarised descriptively. Logistic regression explored sociodemographic and other factors associated with intervention engagement. Mediation analysis investigated whether patient enablement (ability to understand and cope with health issues), treatment use, and barriers to adherence were mediators of intervention effect. Subgroup analysis compared intervention effects among pre-specified participant subsets.Results: A total of 340 parents/carers and 337 young people were recruited. Most parents/carers (87%,n= 148/171) and young people (91%,n= 153/168) in the intervention group viewed the core introduction by 24 weeks. At 24 weeks, users had spent approximately 20 minutes on average on the interventions. Among parents/carers, greater intervention engagement was associated with higher education levels, uncertainty about carrying out treatments, and doubts about treatment efficacy at baseline. Among young people, higher intervention use was associated with higher baseline eczema severity. Patient enablement (the ability to understand and cope with health issues) accounted for approximately 30% of the intervention effect among parents/carers and 50% among young people.Conclusion: This study demonstrated that positive intervention outcomes depended on a modest time commitment from users. This provides further support that the wider implementation of Eczema Care Online is justified.
- Open Access
- 9 January 2024
- Published by Springer Nature in The European Journal of Health Economics
- Vol. 25 (7) , 1165-1176
Cost-effectiveness of two online interventions supporting self-care for eczema for parents/carers and young people
Objective: To estimate the cost-effectiveness of online behavioral interventions (EczemaCareOnline.org.uk) designed to support eczema self-care management for parents/carers and young people from an NHS perspective. Methods: Two within-trial economic evaluations, using regression-based approaches, adjusting for baseline and pre-specified confounder variables, were undertaken alongside two independent, pragmatic, parallel group, unmasked randomized controlled trials, recruiting through primary care. Trial 1 recruited 340 parents/carers of children aged 0–12 years and Trial 2 337 young people aged 13–25 years with eczema scored ≥ 5 on Patient-Oriented Eczema Measure (POEM). Participants were randomized (1:1) to online intervention plus usual care or usual care alone. Resource use, collected via medical notes review, was valued using published unit costs in UK £Sterling 2021. Quality-of-life was elicited using proxy CHU-9D in Trial 1 and self-report EQ-5D-5L in Trial 2. Results: The intervention was dominant (cost saving and more effective) with a high probability of cost-effectiveness (> 68%) in most analyses. The exception was the complete case cost–utility analysis for Trial 1 (omitting participants with children aged < 2), with adjusted incremental cost savings of -£34.15 (95% CI – 104.54 to 36.24) and incremental QALYs of – 0.003 (95% CI – 0.021 to 0.015) producing an incremental cost per QALY of £12,466. In the secondary combined (Trials 1 and 2) cost-effectiveness analysis, the adjusted incremental cost was -£20.35 (95% CI – 55.41 to 14.70) with incremental success (≥ 2-point change on POEM) of 10.3% (95% CI 2.3–18.1%). Conclusion: The free at point of use online eczema self-management intervention was low cost to run and cost-effective. Trial registration: This trial was registered prospectively with the ISRCTN registry (ISRCTN79282252). URL www.EczemaCareOnline.org.uk.
- 9 January 2024
- Published by Springer Nature in The European Journal of Health Economics
- Vol. 25 (7) , 1165-1176
Open AccessCost-effectiveness of two online interventions supporting self-care for eczema for parents/carers and young people
Objective: To estimate the cost-effectiveness of online behavioral interventions (EczemaCareOnline.org.uk) designed to support eczema self-care management for parents/carers and young people from an NHS perspective. Methods: Two within-trial economic evaluations, using regression-based approaches, adjusting for baseline and pre-specified confounder variables, were undertaken alongside two independent, pragmatic, parallel group, unmasked randomized controlled trials, recruiting through primary care. Trial 1 recruited 340 parents/carers of children aged 0–12 years and Trial 2 337 young people aged 13–25 years with eczema scored ≥ 5 on Patient-Oriented Eczema Measure (POEM). Participants were randomized (1:1) to online intervention plus usual care or usual care alone. Resource use, collected via medical notes review, was valued using published unit costs in UK £Sterling 2021. Quality-of-life was elicited using proxy CHU-9D in Trial 1 and self-report EQ-5D-5L in Trial 2. Results: The intervention was dominant (cost saving and more effective) with a high probability of cost-effectiveness (> 68%) in most analyses. The exception was the complete case cost–utility analysis for Trial 1 (omitting participants with children aged < 2), with adjusted incremental cost savings of -£34.15 (95% CI – 104.54 to 36.24) and incremental QALYs of – 0.003 (95% CI – 0.021 to 0.015) producing an incremental cost per QALY of £12,466. In the secondary combined (Trials 1 and 2) cost-effectiveness analysis, the adjusted incremental cost was -£20.35 (95% CI – 55.41 to 14.70) with incremental success (≥ 2-point change on POEM) of 10.3% (95% CI 2.3–18.1%). Conclusion: The free at point of use online eczema self-management intervention was low cost to run and cost-effective. Trial registration: This trial was registered prospectively with the ISRCTN registry (ISRCTN79282252). URL www.EczemaCareOnline.org.uk.
- Open Access
- 7 December 2022
- Published by Oxford University Press (OUP) in British Journal of Dermatology
- Vol. 188 (4) , 506-513
‘Eczema shouldn’t control you; you should control eczema’: qualitative process evaluation of online behavioural interventions to support young people and parents/carers of children with eczema
Background: There is a lack of well-conducted randomized controlled trials evaluating the effectiveness of theory-based online interventions for eczema. To address these deficiencies, we previously developed and demonstrated the effectiveness of two online behavioural interventions: Eczema Care Online for parents/carers of children with eczema, and Eczema Care Online for young people with eczema. Objectives: To explore the views and experiences of people who have used the Eczema Care Online interventions to provide insights into how the interventions worked and identify contextual factors that may impede users’ engagement with the interventions. Methods: Qualitative semistructured interviews were conducted with 17 parents/carers of children with eczema and 17 young people with eczema. Participants were purposively sampled from two randomized controlled trials of the interventions and recruited from GP surgeries in England. Transcripts were analysed using inductive thematic analysis, and intervention modifications were identified using the person-based approach table of changes method. Results: Both young people and parents/carers found the interventions easy to use, relatable and trustworthy, and perceived that they helped them to manage their eczema, thus suggesting that Eczema Care Online may be acceptable to its target groups. Our analysis suggested that the interventions may reduce eczema severity by facilitating empowerment among its users, specifically through improved understanding of, and confidence in, eczema management, reduced treatment concerns, and improved treatment adherence and management of irritants/triggers. Reading about the experiences of others with eczema helped people to feel ‘normal’ and less alone. Some (mainly young people) expressed firmly held negative beliefs about topical corticosteroids, views that were not influenced by the intervention. Minor improvements to the design and navigation of the Eczema Care Online interventions and content changes were identified and made, ready for wider implementation. Conclusions: People with eczema and their families can benefit from reliable information, specifically information on the best and safest ways to use their eczema treatments early in their eczema journey. Together, our findings from this study and the corresponding trials suggest wider implementation of Eczema Care Online (EczemaCareOnline.org.uk) is justified.
- 7 December 2022
- Published by Oxford University Press (OUP) in British Journal of Dermatology
- Vol. 188 (4) , 506-513
Open Access‘Eczema shouldn’t control you; you should control eczema’: qualitative process evaluation of online behavioural interventions to support young people and parents/carers of children with eczema
Background: There is a lack of well-conducted randomized controlled trials evaluating the effectiveness of theory-based online interventions for eczema. To address these deficiencies, we previously developed and demonstrated the effectiveness of two online behavioural interventions: Eczema Care Online for parents/carers of children with eczema, and Eczema Care Online for young people with eczema. Objectives: To explore the views and experiences of people who have used the Eczema Care Online interventions to provide insights into how the interventions worked and identify contextual factors that may impede users’ engagement with the interventions. Methods: Qualitative semistructured interviews were conducted with 17 parents/carers of children with eczema and 17 young people with eczema. Participants were purposively sampled from two randomized controlled trials of the interventions and recruited from GP surgeries in England. Transcripts were analysed using inductive thematic analysis, and intervention modifications were identified using the person-based approach table of changes method. Results: Both young people and parents/carers found the interventions easy to use, relatable and trustworthy, and perceived that they helped them to manage their eczema, thus suggesting that Eczema Care Online may be acceptable to its target groups. Our analysis suggested that the interventions may reduce eczema severity by facilitating empowerment among its users, specifically through improved understanding of, and confidence in, eczema management, reduced treatment concerns, and improved treatment adherence and management of irritants/triggers. Reading about the experiences of others with eczema helped people to feel ‘normal’ and less alone. Some (mainly young people) expressed firmly held negative beliefs about topical corticosteroids, views that were not influenced by the intervention. Minor improvements to the design and navigation of the Eczema Care Online interventions and content changes were identified and made, ready for wider implementation. Conclusions: People with eczema and their families can benefit from reliable information, specifically information on the best and safest ways to use their eczema treatments early in their eczema journey. Together, our findings from this study and the corresponding trials suggest wider implementation of Eczema Care Online (EczemaCareOnline.org.uk) is justified.
- Open Access
- 17 May 2022
- Published by Royal College of General Practitioners in British Journal of General Practice
- Vol. 72 (719) , e378-e389
Supporting families managing childhood eczema: developing and optimising eczema care online using qualitative research
Background: Childhood eczema is often poorly controlled owing to underuse of emollients and topical corticosteroids (TCS). Parents/carers report practical and psychosocial barriers to managing their child’s eczema, including child resistance. Online interventions could potentially support parents/carers; however, rigorous research developing such interventions has been limited.Aim: To develop an online behavioural intervention to help parents/carers manage and co-manage their child’s eczema.Design and setting: Intervention development using a theory-, evidence-, and person-based approach (PBA) with qualitative research.Method: A systematic review and qualitative synthesis of studies (n = 32) and interviews with parents/carers (n = 30) were used to identify barriers and facilitators to effective eczema management, and a prototype intervention was developed. Think-aloud interviews with parents/carers (n = 25) were then used to optimise the intervention to increase its acceptability and feasibility.Results: Qualitative research identified that parents/carers had concerns about using emollients and TCS, incomplete knowledge and skills around managing eczema, and reluctance to transitioning to co-managing eczema with their child. Think-aloud interviews highlighted that, while experienced parents/carers felt they knew how to manage eczema, some information about how to use treatments was still new. Techniques for addressing barriers included providing a rationale explaining how emollients and TCS work, demonstrating how to use treatments, and highlighting that the intervention provided new, up-to-date information.Conclusion: Parents/carers need support in effectively managing and co-managing their child’s eczema. The key output of this research is Eczema Care Online for Families, an online intervention for parents/carers of children with eczema, which is being evaluated in a randomised trial.
- 17 May 2022
- Published by Royal College of General Practitioners in British Journal of General Practice
- Vol. 72 (719) , e378-e389
Open AccessSupporting families managing childhood eczema: developing and optimising eczema care online using qualitative research
Background: Childhood eczema is often poorly controlled owing to underuse of emollients and topical corticosteroids (TCS). Parents/carers report practical and psychosocial barriers to managing their child’s eczema, including child resistance. Online interventions could potentially support parents/carers; however, rigorous research developing such interventions has been limited.Aim: To develop an online behavioural intervention to help parents/carers manage and co-manage their child’s eczema.Design and setting: Intervention development using a theory-, evidence-, and person-based approach (PBA) with qualitative research.Method: A systematic review and qualitative synthesis of studies (n = 32) and interviews with parents/carers (n = 30) were used to identify barriers and facilitators to effective eczema management, and a prototype intervention was developed. Think-aloud interviews with parents/carers (n = 25) were then used to optimise the intervention to increase its acceptability and feasibility.Results: Qualitative research identified that parents/carers had concerns about using emollients and TCS, incomplete knowledge and skills around managing eczema, and reluctance to transitioning to co-managing eczema with their child. Think-aloud interviews highlighted that, while experienced parents/carers felt they knew how to manage eczema, some information about how to use treatments was still new. Techniques for addressing barriers included providing a rationale explaining how emollients and TCS work, demonstrating how to use treatments, and highlighting that the intervention provided new, up-to-date information.Conclusion: Parents/carers need support in effectively managing and co-managing their child’s eczema. The key output of this research is Eczema Care Online for Families, an online intervention for parents/carers of children with eczema, which is being evaluated in a randomised trial.
- Open Access
Eczema Care Online: development and qualitative optimisation of an online behavioural intervention to support self-management in young people with eczema
Objectives To describe the development of Eczema Care Online (ECO), an online behaviour change intervention for young people with eczema (phase I); and explore and optimise the acceptability of ECO among this target group using think-aloud interviews (phase II). Methods Theory-based, evidence-based and person-based approaches to intervention development were used. In phase I, a qualitative systematic review and qualitative interviews developed an in-depth understanding of the needs and challenges of young people with eczema. Guiding principles highlighted key intervention design objectives and features to address the needs of this target group to maximise user engagement. Behavioural analysis and logic modelling developed ECO’s hypothesised programme theory. In phase II, qualitative think-aloud interviews were carried out with 28 young people with eczema and the intervention was optimised based on their feedback. Results The final intervention aimed to reduce eczema severity by supporting treatment use (emollients, topical corticosteroids/topical calcineurin inhibitors), management of irritants/triggers, emotional management and reducing scratching. Generally, young people expressed positive views of intervention content and design in think-aloud interviews. Quotes and stories from other young people with eczema and ECO’s focus on living with eczema (not just topical treatments) were valuable for normalising eczema. Young people believed ECO addressed knowledge gaps they had from childhood and the safety information about topical corticosteroids was reassuring. Negative feedback was used to modify ECO. Conclusions A prototype of the ECO intervention was developed using rigorous and complementary intervention development approaches. Subsequent think-aloud interviews helped optimise the intervention, demonstrated ECO is likely to be acceptable to this target group, and provided support for our guiding principles including key design objectives and features to consider when developing interventions for this population. A randomised controlled trial and process evaluation of the intervention is underway to assess effectiveness and explore user engagement with the intervention’s behavioural goals.
Open AccessEczema Care Online: development and qualitative optimisation of an online behavioural intervention to support self-management in young people with eczema
Objectives To describe the development of Eczema Care Online (ECO), an online behaviour change intervention for young people with eczema (phase I); and explore and optimise the acceptability of ECO among this target group using think-aloud interviews (phase II). Methods Theory-based, evidence-based and person-based approaches to intervention development were used. In phase I, a qualitative systematic review and qualitative interviews developed an in-depth understanding of the needs and challenges of young people with eczema. Guiding principles highlighted key intervention design objectives and features to address the needs of this target group to maximise user engagement. Behavioural analysis and logic modelling developed ECO’s hypothesised programme theory. In phase II, qualitative think-aloud interviews were carried out with 28 young people with eczema and the intervention was optimised based on their feedback. Results The final intervention aimed to reduce eczema severity by supporting treatment use (emollients, topical corticosteroids/topical calcineurin inhibitors), management of irritants/triggers, emotional management and reducing scratching. Generally, young people expressed positive views of intervention content and design in think-aloud interviews. Quotes and stories from other young people with eczema and ECO’s focus on living with eczema (not just topical treatments) were valuable for normalising eczema. Young people believed ECO addressed knowledge gaps they had from childhood and the safety information about topical corticosteroids was reassuring. Negative feedback was used to modify ECO. Conclusions A prototype of the ECO intervention was developed using rigorous and complementary intervention development approaches. Subsequent think-aloud interviews helped optimise the intervention, demonstrated ECO is likely to be acceptable to this target group, and provided support for our guiding principles including key design objectives and features to consider when developing interventions for this population. A randomised controlled trial and process evaluation of the intervention is underway to assess effectiveness and explore user engagement with the intervention’s behavioural goals.